Recombinant Newcastle Disease Virus as a Vaccine Vector for Cancer Therapy
Open Access
- 1 November 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (11) , 1883-1890
- https://doi.org/10.1038/mt.2008.181
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapyVirus Research, 2008
- Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogensProceedings of the National Academy of Sciences, 2007
- Newcastle Disease Virus-Based Live Attenuated Vaccine Completely Protects Chickens and Mice from Lethal Challenge of Homologous and Heterologous H5N1 Avian Influenza VirusesJournal of Virology, 2007
- Engineered viral vaccine constructs with dual specificity: Avian influenza and Newcastle diseaseProceedings of the National Academy of Sciences, 2006
- Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenzaProceedings of the National Academy of Sciences, 2006
- Protection against Respiratory Syncytial Virus by a Recombinant Newcastle Disease Virus VectorJournal of Virology, 2006
- Recombinant Newcastle Disease Virus Expressing a Foreign Viral Antigen Is Attenuated and Highly Immunogenic in PrimatesJournal of Virology, 2005
- A Recombinant Newcastle Disease Virus (NDV) Expressing VP2 Protein of Infectious Bursal Disease Virus (IBDV) Protects against NDV and IBDVJournal of Virology, 2004
- Induction of Cellular Immune Responses to Simian Immunodeficiency Virus Gag by Two Recombinant Negative-Strand RNA Virus VectorsJournal of Virology, 2004
- Mutant Oncopeptide Immunization Induces CTL Specifically Lysing Tumor Cells Endogenously Expressing the Corresponding Intact Mutant p53Hybridoma, 1995